Information:
Fel:
ID
24369
Beskrivning
Study part: Study Conclusion End of Study.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.
Nyckelord
Versioner (1)
- 2017-07-30 2017-07-30 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
30 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Study Conclusion End of Study Ropinirole NCT00632736
Study Conclusion End of Study
- StudyEvent: ODM
Similar models
Study Conclusion End of Study
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1])
Study Subject Participation Status
Item
Was the subject withdrawn from the study?
boolean
C2348568 (UMLS CUI [1])
Item
The primary reason for withdrawal:
text
C0392360 (UMLS CUI [1,1])
C1707478 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1707478 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate))
C0877248 (UMLS CUI-1)
CL Item
Lost to follow-up (Lost to follow-up)
C1302313 (UMLS CUI-1)
CL Item
Protocol violation (Protocol violation)
C1709750 (UMLS CUI-1)
CL Item
Subject decided to withdraw from the study (Subject decided to withdraw from the study)
C2348571 (UMLS CUI-1)
CL Item
Lack of efficacy (Lack of efficacy)
C0235828 (UMLS CUI-1)
CL Item
Sponsor terminated study (Sponsor terminated study)
C1710224 (UMLS CUI-1)
CL Item
Disease progression (Disease progression)
C0242656 (UMLS CUI-1)
CL Item
Other, specify (Other, specify)
C0205394 (UMLS CUI-1)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Not Applicable (not of childbearing potential or male) (Not Applicable (not of childbearing potential or male))
Inga kommentarer